Press "Enter" to skip to content

New patent for Mallinckrodt Hosp drug INOMAX

0

Annual Drug Patent Expirations for INOMAX
Annual Drug Patent Expirations for INOMAX

Inomax is a drug marketed by Mallinckrodt Hosp
and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in INOMAX is nitric oxide. One supplier is listed for this compound. Additional details are available on the nitric oxide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

    Do NOT follow this link or you will be banned from the site!